Remimazolam Impairs Thalamic Auditory Gating During Recovery in Mouse Models

Dysfunction in the thalamic reticular nucleus leads to sensory hypersensitivity and rebound neuronal enhancement following anesthesia.

For Doctors in a Hurry

Clinicians lack clarity on why benzodiazepines cause sensory hypersensitivity and agitation during the immediate postoperative recovery period.
The researchers used electroencephalography and microelectrode recordings to analyze auditory gating in subjects receiving the benzodiazepine remimazolam.
Recovery showed significant auditory gating deficits, with the posterior parietal cortex T2/T1 ratio increasing from 0.38 to 0.82.
The authors conclude that diminished inhibitory activity in thalamic neurons causes exaggerated sensory responses during the recovery phase.
Optimizing postoperative care may require strategies to mitigate these specific sensory processing deficits following benzodiazepine-induced anesthesia.

Sensory Processing and Recovery from Benzodiazepine Anesthesia

Remimazolam has gained clinical traction as an ultra-short-acting benzodiazepine that offers hemodynamic stability compared to propofol, particularly in elderly populations [1, 2]. While meta-analyses suggest it does not significantly increase the overall risk of postoperative delirium in most cohorts, its impact on the quality of early recovery remains a subject of active investigation [3, 4]. Clinicians frequently observe sensory hypersensitivity and agitation as patients emerge from anesthesia, complications that can prolong recovery and increase nursing requirements [2, 4]. These behavioral disturbances are often linked to the brain's inability to process environmental stimuli appropriately during the transition to wakefulness. A new study now offers insights into the specific subcortical mechanisms that govern sensory filtering during the post-anesthetic period.

Quantifying Post-Anesthetic Auditory Gating Deficits

To understand why patients often experience agitation upon emergence, the researchers investigated the mechanism of auditory gating, which is the brain's physiological process of filtering out redundant or repetitive environmental sounds to prevent sensory network overload. The study utilized mouse models to evaluate how remimazolam influences these sensory filters across different arousal states. Researchers employed a comprehensive monitoring suite that included simultaneous electroencephalography (EEG) to track brain wave patterns, electromyography (EMG) to measure muscle activity, and detailed behavioral analyses. To capture high-resolution data on how individual neurons communicate, the team used multi-region microelectrodes and Neuropixels probes (high-density silicon sensors capable of recording the electrical activity of hundreds of individual neurons simultaneously) to record cortical and subcortical local field potentials and single-unit activity. The data revealed a distinct biphasic response in the brain's processing of sound. During the active phases of anesthesia and sedation, the researchers observed that both spontaneous and paired-tone evoked neuronal activity were suppressed across the recorded regions. However, as the medication began to clear, the neural landscape shifted. During the recovery phase, the mice exhibited rebound enhancement and significant auditory gating deficits, characterized by an inability to suppress the second of two closely timed tones. This failure in sensory filtering was quantified by the T2/T1 ratio, a metric where a higher value indicates a failure to gate the second stimulus. In the posterior parietal cortex, a region essential for integrating sensory information and spatial awareness, the ratio rose from a baseline of 0.38 (0.01) to 0.82 (0.02) during recovery (P < 0.001). Similar failures were recorded in the dorsal hippocampus, which shifted from 0.34 (0.01) to 1.10 (0.03) (P < 0.001), and the mediodorsal thalamic nucleus, which increased from 0.48 (0.01) to 1.12 (0.02) (P < 0.001).

Regional Evidence of Sensory Filtering Failure

The researchers quantified the breakdown of sensory processing by calculating the T2/T1 ratio, which compares the brain's electrical response to a second, redundant auditory stimulus (T2) against the initial stimulus (T1). In a healthy, functioning state, the brain suppresses the response to the second tone, resulting in a low ratio. However, during the recovery phase from remimazolam, this filtering mechanism failed significantly across multiple critical brain regions. A T2/T1 ratio approaching or exceeding 1.0 signifies a total loss of auditory gating, meaning the brain treats repetitive environmental noise as if it were new and potentially threatening information. This loss of habituation may explain the clinical presentation of emergence agitation. The most pronounced deficits occurred in regions responsible for spatial awareness, memory, and sensory relay. In the posterior parietal cortex, the T2/T1 ratio increased from a baseline of 0.38 [0.01] to 0.82 [0.02] during recovery (P < 0.001). Even more striking results were observed in the dorsal hippocampus, where the ratio shifted from a baseline of 0.34 [0.01] to 1.10 [0.03] (P < 0.001), and in the mediodorsal thalamic nucleus, which rose from 0.48 [0.01] at baseline to 1.12 [0.02] during recovery (P < 0.001). These values, which exceed 1.0, indicate that the neurons in these regions were actually more reactive to the second tone than the first, a state of rebound enhancement that likely contributes to the clinical phenomenon of post-anesthetic hypersensitivity.

Imbalance of Top-Down and Bottom-Up Circuitry

To investigate the specific neural pathways disrupted by remimazolam, the researchers employed optogenetics (a technique that uses light to selectively activate or inhibit specific populations of neurons that have been genetically modified to express light-sensitive proteins). This method allowed the team to isolate the roles of the prefrontal cortex, which provides top-down executive control over sensory processing, and the brainstem auditory nuclei, the primary source of bottom-up sensory information. The study found that during the state of active anesthesia, both top-down inputs from the prefrontal cortex and bottom-up inputs from the brainstem auditory nuclei were effectively blocked. This dual inhibition explains the profound suppression of sensory awareness required for surgical procedures, as the brain is shielded from external stimuli while simultaneously losing its higher-order regulatory signals. The transition from anesthesia to wakefulness revealed a significant physiological imbalance between these two pathways. As the effects of remimazolam began to wane during the recovery phase, the researchers observed that top-down inputs from the prefrontal cortex normalized, returning to their pre-anesthetic baseline levels of activity. In contrast, the bottom-up inputs from the brainstem auditory nuclei did not simply return to normal but instead exceeded baseline levels. This surge in ascending sensory signals, occurring while the brain's filtering mechanisms are still recovering, creates a state of sensory overload. This mismatch between normalized executive control and hyperactive sensory input provides a mechanistic explanation for why patients may experience heightened auditory responsiveness and agitation as they emerge from benzodiazepine-induced sedation.

Thalamic Reticular Nucleus Dysfunction and Clinical Implications

The researchers identified a specific cellular mechanism within the thalamic reticular nucleus, a region that acts as a primary relay and filter for sensory information entering the cortex. Specifically, the study focused on a subset of gamma-aminobutyric acid (GABA)ergic neurons, which are inhibitory nerve cells that use the neurotransmitter GABA to reduce neuronal excitability. These particular neurons exhibited sustained responses to paired tones under normal conditions, serving as a critical component of the brain's auditory gating system by providing inhibitory feedback to prevent the cortex from being overwhelmed by repetitive sensory signals. During the recovery phase following remimazolam administration, the functional capacity of these inhibitory circuits was significantly compromised. The study found that the proportion of responsive GABAergic neurons in the thalamic reticular nucleus was only 29.3 percent, a marked decrease from the 63.0 percent observed at baseline. Beyond the reduction in the number of active cells, the intensity of the remaining neuronal activity was also suppressed. The maximum firing rate of these neurons during recovery was 17.4 [3.0], compared to a baseline of 28.9 [3.9] (P < 0.001). This quantitative decline in both recruitment and firing frequency suggests that the thalamic filter remains functionally impaired even as other arousal measures begin to normalize. This diminished activity in the thalamic reticular nucleus resulted in insufficient inhibition of bottom-up inputs, leading to a state where the brain cannot effectively filter ascending sensory information. For the clinician, these findings offer a mechanistic explanation for why perioperative benzodiazepines increase the risk of sensory hypersensitivity and agitation during recovery. Because the thalamic reticular nucleus fails to dampen incoming signals, the patient experiences exaggerated responses to external stimuli, suggesting that this nucleus is a critical site for post-anesthetic sensory regulation.

Study Info

Remimazolam-induced dysfunction of thalamic reticular nucleus impairs auditory gating during postanaesthetic recovery in mice

Shuai Wang, Zijie Li, Xuejiao Wang, Ming Xu, et al.

Journal British Journal of Anaesthesia

Published April 01, 2026